<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10403270" created="02/07/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10403270</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="A11" sem="Protein_family_or_group"><term id="T1" lex="monoclonal_anti-endothelial_cell_antibody" sem="Protein_family_or_group">Monoclonal anti-endothelial cell antibodies</term> from a patient with <term id="T2" lex="Takayasu_arteritis" sem="Other">Takayasu arteritis</term></term> activate <term id="A1" sem="Cell_natural">endothelial cells from <term id="T3" lex="large_vessel" sem="Tissue_natural">large vessels</term></term>.</sentence>
<event id="E1">
<type class="Physiological_process"/>
<theme idref="A1"/>
<cause idref="A11"/>
<clue>Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis <clueType>activate</clueType> endothelial cells from large vessels.</clue>
<comment>TPS: A1</comment></event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">OBJECTIVE: To create <term id="T4" lex="monoclonal_anti-endothelial_cell_antibody" sem="Protein_family_or_group">monoclonal anti-endothelial cell antibodies</term> (<term id="T5" lex="mAECA" sem="Protein_family_or_group">mAECA</term>) from a patient with <term id="T6" lex="Takayasu_arteritis" sem="Other">Takayasu arteritis</term> to evaluate their ability to activate <term id="T7" lex="human_umbilical_vein_endothelial_cell" sem="Cell_cultured">human umbilical vein endothelial cells</term> (<term id="T8" lex="HUVEC" sem="Cell_cultured">HUVEC</term>), and to characterize the mechanism of <term id="T9" lex="EC_activation" sem="Other"><term id="A2" sem="Cell_natural">EC</term> activation</term>.</sentence>
<event KT="Investigation" id="E2" uncertainty="doubtful">
<type class="Physiological_process"/>
<theme idref="T8"/>
<cause idref="T5"/>
<clue>OBJECTIVE: To create monoclonal anti-endothelial cell antibodies (mAECA) from a patient with Takayasu arteritis <clueKT>to evaluate</clueKT> their ability to <clueType>activate</clueType> human umbilical vein endothelial cells (HUVEC), and to characterize the mechanism of EC activation.</clue>
</event>
<event KT="Investigation" id="E3" uncertainty="doubtful">
<type class="Physiological_process"/>
<theme idref="A2"/>
<clue>OBJECTIVE: To create monoclonal anti-endothelial cell antibodies (mAECA) from a patient with Takayasu arteritis to evaluate their ability to activate human umbilical vein endothelial cells (HUVEC), and <clueKT>to characterize</clueKT> the mechanism of EC <clueType>activation</clueType>.</clue>
</event>
<sentence id="S3">METHODS: A panel of <term id="T10" lex="mAECA" sem="Protein_family_or_group">mAECA</term> was generated from <term id="T11" lex="peripheral_blood_lymphocyte" sem="Cell_natural">peripheral blood lymphocytes</term> of a patient with <term id="T12" lex="Takayasu_arteritis" sem="Other">Takayasu arteritis</term>, using <term id="T13" lex="Epstein-Barr_virus_transformation" sem="Other">Epstein-Barr virus transformation</term>.</sentence>
<sentence id="S4">Activity against <term id="T14" lex="macrovascular_EC" sem="Cell_cultured">macrovascular EC</term> (<term id="T15" lex="HUVEC" sem="Cell_cultured">HUVEC</term>) and <term id="T16" lex="microvascular_EC_(human_bone_marrow_EC_immortalized_by_SV40)_antigen" sem="Peptide"><term id="T17" lex="microvascular_EC" sem="Cell_cultured">microvascular EC</term> (<term id="T18" lex="human_bone_marrow_EC_immortalized_by_SV40" sem="Cell_cultured">human <term id="A10" sem="Cell_natural">bone marrow EC</term> immortalized by <term id="T19" lex="SV40" sem="Virus">SV40</term></term>) antigens</term> was detected by <term id="T20" lex="enzyme-linked_immunosorbent_assay" sem="Other">enzyme-linked immunosorbent assay</term>.</sentence>
<event id="E4" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T15"/>
<cause idref="T10"/>
<clue><clueType>Activity</clueType> <linkTheme>against</linkTheme> macrovascular EC (HUVEC) and microvascular EC (human bone marrow EC immortalized by SV40) antigens was <clueKT>detected</clueKT> <clueExperiment>by enzyme-linked immunosorbent assay</clueExperiment>.</clue>
<comment>NO COREFCAUSE</comment></event>
<event id="E5" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T17"/>
<cause idref="T10"/>
<clue><clueType>Activity</clueType> <linkTheme>against</linkTheme> macrovascular EC (HUVEC) and microvascular EC (human bone marrow EC immortalized by SV40) antigens was <clueKT>detected</clueKT> <clueExperiment>by enzyme-linked immunosorbent assay</clueExperiment>.</clue>
<comment>NO COREFCAUSE</comment></event>
<event KT="Other" id="E46">
<type class="Biological_process"/>
<theme idref="A10"/>
<clue>Activity against macrovascular EC (HUVEC) and microvascular EC (human bone marrow EC <clueType>immortalized</clueType> <linkTheme>by</linkTheme> SV40) antigens was detected by enzyme-linked immunosorbent assay.</clue>
</event>
<event KT="Fact" id="E47">
<type class="Positive_regulation"/>
<theme idref="E46"/>
<theme idref="T19"/>
<clue>Activity against macrovascular EC (HUVEC) and microvascular EC (human bone marrow EC <clueType>immortalized</clueType> <linkCause>by</linkCause> SV40) antigens was detected by enzyme-linked immunosorbent assay.</clue>
</event>
<sentence id="S5">Inhibition studies were used to select the <term id="T21" lex="monoclonal_antibody" sem="Protein_family_or_group">monoclonal antibodies</term> (<term id="T22" lex="mAECA" sem="Protein_family_or_group">mAECA</term>) which share the same <term id="T23" lex="EC_epitope_binding_specificity" sem="Other"><term id="A3" sem="Protein_domain_or_region">EC epitope</term> binding specificity</term> as the <term id="T24" lex="total_IgG-AECA" sem="Protein_molecule">total IgG-AECA</term> from the <term id="T25" lex="Takayasu_arteritis_patient" sem="Multicellular_organism_natural"><term id="T26" lex="Takayasu_arteritis" sem="Other">Takayasu arteritis</term> patient</term>.</sentence>
<event KT="Other" id="E6" uncertainty="doubtful">
<type class="Binding"/>
<theme idref="T22"/>
<theme idref="A3"/>
<clue><clueExperiment>Inhibition studies</clueExperiment> were used to select the monoclonal antibodies (mAECA) which share the same EC epitope <clueType>binding</clueType> specificity as the total IgG-AECA from the Takayasu arteritis patient.</clue>
</event>
<event KT="Other" id="E7" uncertainty="doubtful">
<type class="Binding"/>
<theme idref="T24"/>
<theme idref="A3"/>
<clue><clueExperiment>Inhibition studies</clueExperiment> were used to select the monoclonal antibodies (mAECA) which share the same EC epitope <clueType>binding</clueType> specificity as the total IgG-AECA from the Takayasu arteritis patient.</clue>
</event>
<sentence id="S6">The binding of the <term id="T27" lex="mAECA" sem="Protein_family_or_group">mAECA</term> to <term id="T28" lex="human_aortic_EC" sem="Cell_natural">human aortic EC</term> was studied by <term id="T29" lex="immunohistochemistry" sem="Other">immunohistochemistry</term>.</sentence>
<event KT="Investigation" id="E8" uncertainty="doubtful">
<type class="Cell_adhesion"/>
<theme idref="T27"/>
<theme idref="T28"/>
<clue>The <clueType>binding</clueType> <linkTheme>of</linkTheme> the mAECA <linkTheme>to</linkTheme> human aortic EC was <clueKT>studied</clueKT> <clueExperiment>by immunohistochemistry</clueExperiment>.</clue>
</event>
<sentence id="S7">The secretion levels of <term id="T30" lex="interleukin-6" sem="Protein_molecule">interleukin-6</term> (<term id="T31" lex="IL-6" sem="Protein_molecule">IL-6</term>) and <term id="T32" lex="von_Willebrand_factor" sem="Protein_molecule">von Willebrand factor</term> (<term id="T33" lex="vWF" sem="Protein_molecule">vWF</term>) were determined, to serve as markers for <term id="T34" lex="EC_activation" sem="Other"><term id="A4" sem="Cell_natural">EC</term> activation</term>.</sentence>
<event KT="Analysis" id="E9" uncertainty="doubtful">
<type class="Localization"/>
<theme idref="T31"/>
<clue>The <clueType>secretion</clueType> levels <linkTheme>of</linkTheme> interleukin-6 (IL-6) and von Willebrand factor (vWF) were <clueKT>determined</clueKT>, to serve as markers for EC activation.</clue>
</event>
<event KT="Analysis" id="E10" uncertainty="doubtful">
<type class="Localization"/>
<theme idref="T33"/>
<clue>The <clueType>secretion</clueType> levels <linkTheme>of</linkTheme> interleukin-6 (IL-6) and von Willebrand factor (vWF) were <clueKT>determined</clueKT>, to serve as markers for EC activation.</clue>
<comment>NER: T32 &amp; T33 sem mod, Other_name -&gt; Protein_molecule</comment></event>
<event KT="Other" id="E11" uncertainty="doubtful">
<type class="Physiological_process"/>
<theme idref="A4"/>
<clue><clueExperiment>The secretion levels of interleukin-6 (IL-6) and von Willebrand factor (vWF) were determined</clueExperiment>, to serve as markers for EC <clueType>activation</clueType>.</clue>
</event>
<sentence id="S8">The <term id="T35" lex="activated_EC" sem="Cell_cultured">activated <term id="A5" sem="Cell_natural">EC</term></term> were examined for the adherence of a <term id="T36" lex="monocytic_cell_line" sem="Cell_cultured">monocytic cell line</term> (<term id="T37" lex="U937" sem="Cell_cultured">U937</term>), as well as for expression of <term id="T38" lex="vascular_cell_adhesion_molecule_1" sem="Protein_molecule">vascular cell adhesion molecule 1</term>, <term id="T39" lex="intercellular_adhesion_molecule_1" sem="Protein_molecule">intercellular adhesion molecule 1</term>, and <term id="T40" lex="E-selectin" sem="Protein_molecule">E-selectin</term>.</sentence>
<event KT="Other" id="E12">
<type class="Physiological_process"/>
<theme idref="A5"/>
<clue>The <clueType>activated</clueType> EC were examined for the adherence of a monocytic cell line (U937), as well as for expression of vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and E-selectin.</clue>
</event>
<event KT="Investigation" id="E13" uncertainty="doubtful">
<type class="Cell_adhesion"/>
<theme idref="T35"/>
<theme idref="T37"/>
<clue>The activated EC were <clueKT>examined</clueKT> for the <clueType>adherence</clueType> <linkTheme>of</linkTheme> a monocytic cell line (U937), as well as for expression of vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and E-selectin.</clue>
</event>
<event KT="Investigation" id="E14" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T38"/>
<clue>The <clueLoc>activated EC</clueLoc> were <clueKT>examined</clueKT> for the adherence of a monocytic cell line (U937), as well as for <clueType>expression</clueType> <linkTheme>of</linkTheme> vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and E-selectin.</clue>
</event>
<event KT="Investigation" id="E15" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T39"/>
<clue>The <clueLoc>activated EC</clueLoc> were <clueKT>examined</clueKT> for the adherence of a monocytic cell line (U937), as well as for <clueType>expression</clueType> <linkTheme>of</linkTheme> vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and E-selectin.</clue>
</event>
<event KT="Investigation" id="E16" uncertainty="doubtful">
<type class="Gene_expression"/>
<theme idref="T40"/>
<clue>The <clueLoc>activated EC</clueLoc> were <clueKT>examined</clueKT> for the adherence of a monocytic cell line (U937), as well as for <clueType>expression</clueType> <linkTheme>of</linkTheme> vascular cell adhesion molecule 1, intercellular adhesion molecule 1, and E-selectin.</clue>
</event>
<sentence id="S9">In addition, <term id="T41" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> of the <term id="T42" lex="mAECA-treated_EC" sem="Cell_cultured"><term id="T43" lex="mAECA" sem="Protein_family_or_group">mAECA</term>-treated <term id="A6" sem="Cell_natural">EC</term></term> were analyzed for the induction of translocation of <term id="T44" lex="nuclear_factor_kappaB" sem="Protein_complex">nuclear factor kappaB</term> (<term id="T45" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>), using a specific <term id="T46" lex="NF-kappaB_oligoprobe" sem="Polynucleotide"><term id="T47" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> oligoprobe</term> in an <term id="T48" lex="electrophoretic_mobility_shift_assay" sem="Other">electrophoretic mobility shift assay</term>.</sentence>
<event KT="Method" id="E17">
<type class="Artificial_process"/>
<theme idref="A6"/>
<theme idref="T43"/>
<clue>In addition, nuclear extracts of the mAECA-<clueType>treated</clueType> EC were analyzed for the induction of translocation of nuclear factor kappaB (NF-kappaB), using a specific NF-kappaB oligoprobe in an electrophoretic mobility shift assay.</clue>
</event>
<event KT="Investigation" id="E18" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="T41" idref1="E17"/>
<clue>In addition, nuclear extracts of the mAECA-treated EC were <clueKT>analyzed</clueKT> for the <clueType>induction</clueType> <linkTheme>of</linkTheme> translocation of nuclear factor kappaB (NF-kappaB), using a specific NF-kappaB oligoprobe in an electrophoretic mobility shift assay.</clue>
</event>
<event KT="Other" id="E19" uncertainty="doubtful">
<type class="Localization"/>
<theme idref="T45"/>
<clue>In addition, <clueLoc>nuclear extracts of the mAECA-treated EC</clueLoc> were analyzed for the induction of <clueType>translocation</clueType> <linkTheme>of</linkTheme> nuclear factor kappaB (NF-kappaB), <clueExperiment>using a specific NF-kappaB oligoprobe in an electrophoretic mobility shift assay</clueExperiment>.</clue>
</event>
<sentence id="S10">RESULTS: Six <term id="T49" lex="mAECA" sem="Protein_family_or_group">mAECA</term> were selected, the mixture of which produced 100% inhibition of binding of the original <term id="T50" lex="IgG" sem="Protein_family_or_group">IgG</term> (from the patient with <term id="T51" lex="Takayasu_arteritis" sem="Other">Takayasu arteritis</term>) to <term id="T52" lex="HUVEC" sem="Cell_cultured">HUVEC</term>.</sentence>
<event Manner="High" id="E20">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<cause idref="T49"/>
<clue>RESULTS: Six mAECA were selected, the mixture of which produced <clueManner>100%</clueManner> <clueType>inhibition</clueType> <linkTheme>of</linkTheme> binding of the original IgG (from the patient with Takayasu arteritis) to HUVEC.</clue>
</event>
<event KT="Other" id="E21">
<type class="Cell_adhesion"/>
<theme idref="T50"/>
<theme idref="T52"/>
<clue>RESULTS: Six mAECA were selected, the mixture of which produced 100% inhibition of <clueType>binding</clueType> <linkTheme>of</linkTheme> the original IgG (from the patient with Takayasu arteritis) <linkTheme>to</linkTheme> HUVEC.</clue>
</event>
<sentence id="S11">All <term id="T53" lex="mAECA" sem="Protein_family_or_group">mAECA</term> possessed high activity against <term id="T54" lex="macrovascular_EC" sem="Cell_cultured">macrovascular EC</term>, but none had significant <term id="T55" lex="antimicrovascular_EC_activity" sem="Other">anti<term id="A7" sem="Cell_natural">microvascular EC</term> activity</term>.</sentence>
<event Manner="High" id="E22">
<type class="Negative_regulation"/>
<theme idref="T54"/>
<cause idref="T53"/>
<clue>All mAECA possessed <clueManner>high</clueManner> <clueType>activity</clueType> <linkTheme>against</linkTheme> macrovascular EC, but none had significant antimicrovascular EC activity.</clue>
<comment>CAUTION: inhibitory</comment></event>
<event Manner="High" Polarity="Negative" assertion="non-exist" id="E23">
<type class="Negative_regulation"/>
<theme idref="A7"/>
<cause idref="T53"/>
<clue>All mAECA possessed high activity against macrovascular EC, but <cluePolarity>none</cluePolarity> had <clueManner>significant</clueManner> <clueType>anti</clueType>microvascular EC <clueType>activity</clueType>.</clue>
</event>
<sentence id="S12">The <term id="T56" lex="mAECA" sem="Protein_family_or_group">mAECA</term>, but not <term id="T57" lex="normal_human_IgG" sem="Protein_family_or_group">normal human IgG</term>, had <term id="T59" lex="anti-human_aortic_EC_activity" sem="Other">anti-<term id="A9" sem="Cell_natural">human aortic EC</term> activity</term>.</sentence>
<event id="E24">
<type class="Negative_regulation"/>
<theme idref="A9"/>
<cause idref="T56"/>
<clue>The mAECA, but not normal human IgG, had <clueType>anti</clueType>-human aortic EC <clueType>activity</clueType>.</clue>
<comment>NER: T58 del &quot;IgG&quot;</comment></event>
<event Polarity="Negative" assertion="non-exist" id="E25">
<type class="Negative_regulation"/>
<theme idref="A9"/>
<cause idref="T57"/>
<clue>The mAECA, but <cluePolarity>not</cluePolarity> normal human IgG, had <clueType>anti</clueType>-human aortic EC <clueType>activity</clueType>.</clue>
</event>
<sentence id="S13">Four of the 6 <term id="T60" lex="mAECA" sem="Protein_family_or_group">mAECA</term> <term id="T61" lex="activated_EC" sem="Cell_cultured">activated <term id="A8" sem="Cell_natural">EC</term></term>, manifested by increased <term id="T62" lex="IL-6" sem="Protein_molecule">IL-6</term> and <term id="T63" lex="vWF_secretion" sem="Other"><term id="T64" lex="vWF" sem="Protein_molecule">vWF</term> secretion</term>.</sentence>
<event id="E26">
<type class="Physiological_process"/>
<theme idref="A8"/>
<cause idref="T60"/>
<clue>Four of the 6 mAECA <clueType>activated</clueType> EC, manifested by increased IL-6 and vWF secretion.</clue>
</event>
<event id="E27">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="T60"/>
<clue>Four of the 6 mAECA <clueLoc>activated EC</clueLoc>, manifested by <clueType>increased</clueType> IL-6 and vWF secretion.</clue>
</event>
<event id="E28">
<type class="Positive_regulation"/>
<theme idref="E30"/>
<cause idref="T60"/>
<clue>Four of the 6 mAECA <clueLoc>activated EC</clueLoc>, manifested by <clueType>increased</clueType> IL-6 and vWF secretion.</clue>
</event>
<event id="E29">
<type class="Localization"/>
<theme idref="T62"/>
<clue>Four of the 6 mAECA activated EC, manifested by increased IL-6 and vWF <clueType>secretion</clueType>.</clue>
</event>
<event id="E30">
<type class="Localization"/>
<theme idref="T64"/>
<clue>Four of the 6 mAECA activated EC, manifested by increased IL-6 and vWF <clueType>secretion</clueType>.</clue>
<comment>NER: T64 sem mod, Other_name -&gt; Protein_molecule</comment></event>
<sentence id="S14">The 4 <term id="T65" lex="mAECA" sem="Protein_family_or_group">mAECA</term> induced <term id="T66" lex="EC_expression" sem="Other">EC expression</term> of <term id="T67" lex="adhesion_molecule" sem="Protein_family_or_group">adhesion molecules</term> and increased adhesion of <term id="T68" lex="U937_monocytic_cell" sem="Cell_natural"><term id="T69" lex="U937" sem="Cell_cultured">U937</term> monocytic cells</term> to <term id="T70" lex="EC" sem="Cell_natural">EC</term>.</sentence>
<event id="E31">
<type class="Gene_expression"/>
<theme idref="T67"/>
<clue>The 4 mAECA induced <clueLoc>EC</clueLoc> <clueType>expression</clueType> <linkTheme>of</linkTheme> adhesion molecules and increased adhesion of U937 monocytic cells to EC.</clue>
</event>
<event id="E32">
<type class="Positive_regulation"/>
<theme idref="E31"/>
<cause idref="T65"/>
<clue>The 4 mAECA <clueType>induced</clueType> EC expression of adhesion molecules and increased adhesion of U937 monocytic cells to EC.</clue>
</event>
<event id="E33">
<type class="Positive_regulation"/>
<theme idref="E34"/>
<cause idref="T65"/>
<clue>The 4 mAECA induced EC expression of adhesion molecules and <clueType>increased</clueType> adhesion of U937 monocytic cells to EC.</clue>
</event>
<event id="E34">
<type class="Cell_adhesion"/>
<theme idref="T69"/>
<theme idref="T70"/>
<clue>The 4 mAECA induced EC expression of adhesion molecules and increased <clueType>adhesion</clueType> <linkTheme>of</linkTheme> U937 monocytic cells <linkTheme>to</linkTheme> EC.</clue>
</event>
<sentence id="S15">In addition, these <term id="T71" lex="mAECA" sem="Protein_family_or_group">mAECA</term> stimulated the <term id="T72" lex="nuclear_translocation" sem="Other">nuclear translocation</term> of the <term id="T73" lex="NF-kappaB_transcription_factor" sem="Protein_complex"><term id="T74" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> transcription factor</term>.</sentence>
<event id="E35">
<type class="Positive_regulation"/>
<theme idref="E36"/>
<cause idref="T71"/>
<clue>In addition, these mAECA <clueType>stimulated</clueType> the nuclear translocation of the NF-kappaB transcription factor.</clue>
</event>
<event id="E36">
<type class="Localization"/>
<theme idref="T74"/>
<clue>In addition, these mAECA stimulated the <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> <linkTheme>of</linkTheme> the NF-kappaB transcription factor.</clue>
</event>
<sentence id="S16">CONCLUSION: Our findings suggest that <term id="T75" lex="AECA" sem="Protein_molecule">AECA</term> may directly stimulate <term id="T76" lex="EC" sem="Cell_natural">EC</term> in <term id="T77" lex="Takayasu_arteritis" sem="Other">Takayasu arteritis</term> through elevation of <term id="T78" lex="adhesion_molecule_expression" sem="Other"><term id="T79" lex="adhesion_molecule" sem="Protein_family_or_group">adhesion molecule</term> expression</term> associated with <term id="T80" lex="NF-kappaB_activation" sem="Other"><term id="T81" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> activation</term> and adhesion of <term id="T82" lex="monocyte" sem="Cell_natural">monocytes</term>, and may therefore play a pathogenic role in the development of the <term id="T83" lex="vasculopathy" sem="Other">vasculopathy</term> in <term id="T84" lex="Takayasu_arteritis" sem="Other">Takayasu arteritis</term>.</sentence>
<event CL="L1" KT="Analysis" id="E37" uncertainty="probable">
<type class="Physiological_process"/>
<theme idref="T76"/>
<cause idref="E38"/>
<clue>CONCLUSION: Our findings <clueKT>suggest</clueKT> that AECA <clueCL>may</clueCL> directly <clueType>stimulate</clueType> EC in Takayasu arteritis <linkCause>through</linkCause> elevation of adhesion molecule expression associated with NF-kappaB activation and adhesion of monocytes, and may therefore play a pathogenic role in the development of the vasculopathy in Takayasu arteritis.</clue>
</event>
<event KT="Other" id="E38" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E39"/>
<cause idref="T75"/>
<clue>CONCLUSION: Our findings suggest that AECA may directly stimulate EC in Takayasu arteritis through <clueType>elevation</clueType> <linkTheme>of</linkTheme> adhesion molecule expression associated with NF-kappaB activation and adhesion of monocytes, and may therefore play a pathogenic role in the development of the vasculopathy in Takayasu arteritis.</clue>
</event>
<event KT="Other" id="E39" uncertainty="probable">
<type class="Gene_expression"/>
<theme idref="T79"/>
<clue>CONCLUSION: Our findings suggest that AECA may directly stimulate EC in Takayasu arteritis through elevation of adhesion molecule <clueType>expression</clueType> associated with NF-kappaB activation and adhesion of monocytes, and may therefore play a pathogenic role in the development of the vasculopathy in Takayasu arteritis.</clue>
</event>
<event KT="Analysis" id="E40">
<type class="Correlation"/>
<theme idref="E38"/>
<theme idref="E42"/>
<clue>CONCLUSION: Our findings suggest that AECA may directly stimulate EC in Takayasu arteritis through elevation of adhesion molecule expression <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> NF-kappaB activation and adhesion of monocytes, and may therefore play a pathogenic role in the development of the vasculopathy in Takayasu arteritis.</clue>
</event>
<event KT="Analysis" id="E41">
<type class="Correlation"/>
<theme idref="E38"/>
<theme idref="E43"/>
<clue>CONCLUSION: Our findings suggest that AECA may directly stimulate EC in Takayasu arteritis through elevation of adhesion molecule expression <clueType><clueKT>associated</clueKT></clueType> <linkTheme>with</linkTheme> NF-kappaB activation and adhesion of monocytes, and may therefore play a pathogenic role in the development of the vasculopathy in Takayasu arteritis.</clue>
</event>
<event KT="Other" id="E42">
<type class="Positive_regulation"/>
<theme idref="T81"/>
<clue>CONCLUSION: Our findings suggest that AECA may directly stimulate EC in Takayasu arteritis through elevation of adhesion molecule expression associated with NF-kappaB <clueType>activation</clueType> and adhesion of monocytes, and may therefore play a pathogenic role in the development of the vasculopathy in Takayasu arteritis.</clue>
</event>
<event KT="Other" id="E43">
<type class="Cell_adhesion"/>
<theme idref="T76"/>
<theme idref="T82"/>
<clue>CONCLUSION: Our findings suggest that AECA may directly stimulate EC in Takayasu arteritis through elevation of adhesion molecule expression associated with NF-kappaB activation and <clueType>adhesion</clueType> <linkTheme>of</linkTheme> monocytes, and may therefore play a pathogenic role in the development of the vasculopathy in Takayasu arteritis.</clue>
</event>
<event CL="L1" KT="Analysis" id="E44" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E45"/>
<cause idref="T75"/>
<clue>CONCLUSION: Our findings suggest that AECA may directly stimulate EC in Takayasu arteritis through elevation of adhesion molecule expression associated with NF-kappaB activation and adhesion of monocytes, and <clueCL>may</clueCL> <clueKT>therefore</clueKT> <clueType>play</clueType> a pathogenic <clueType>role</clueType> <linkTheme>in</linkTheme> the development of the vasculopathy in Takayasu arteritis.</clue>
</event>
<event KT="Other" id="E45">
<type class="Physiological_process"/>
<theme idref="T83"/>
<clue>CONCLUSION: Our findings suggest that AECA may directly stimulate EC in Takayasu arteritis through elevation of adhesion molecule expression associated with NF-kappaB activation and adhesion of monocytes, and may therefore play a pathogenic role in the <clueType>development</clueType> <linkTheme>of</linkTheme> the vasculopathy in Takayasu arteritis.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
